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Shy and/or fearful temperament not associated with IgE mediated food allergy in early childhood
Renata Ndahayo
1 , Victoria Martin, MD RATIONALE: Anxiety has been associated with food allergy in school age children. It is unclear whether that association is the consequence of or contributes to risk for food allergy. The Early Childhood Behavior Questionnaire (ECBQ) is a validated measure of toddler temperament that has been associated with subsequent childhood anxiety. We hypothesized that increased shyness and or fear as a toddler would be associated with food allergy. METHODS: ECBQ was completed by a parent for 364 toddlers (median, 20 months) in a prospective infant cohort, 29 (8%) of whom have an IgEmediated food allergy (overall rate 6%). Shyness and fear were measured on a likert scale. Wilcoxon rank sum and Pearson's Chi-squared tests were used to evaluate for associations between ECBQ, food refusal and food allergy. RESULTS: Shyness and fear measured by the ECBQ were correlated with each other (r 5 0.5, p < 0.01). The median shyness score among participants with food allergy was 3.25[2.5 -4.2] versus 3[2.5 -3.8] (p50.16). There was also no significant difference in fear score (2[1.8 -2.6] vs 2[1.6 -2.7]; p50.57. was a positive and significant association between parent reported food refusal (n5137) and shyness (p50.014). Despite this association, cases of IgE-mediated allergy were no more frequent among those reporting food refusal (p51). CONCLUSIONS: Shy or fearful temperament were not cross-sectionally associated with presence of food allergies in toddlerhood. Previously observed associations between food allergy and anxiety may be more likely a consequence of food allergy than due to shared neurobehavioral underpinnings of the two conditions.
Successful Administration of Yellow Fever Vaccine in Egg-allergic Patients
Clarissa Morais Busatto Gerhardt, Gislane S. Juliao, Bruna Pultrini Aquilante, Cristiane N. Santos, MD, Mayra de Barros Dorna, Antonio Carlos Pastorino, MD, PhD, and Ana Paula Moschione Castro, MD, PhD; University of Sao Paulo, Sao Paulo, Brazil. RATIONALE: The yellow fever vaccine (YFV) is recommended in endemic areas but represents a risk for egg-allergic patients, as it is cultivated in chicken embryos. This study aims to describe the outcomes of yellow fever vaccination in patients with confirmed egg allergy (EA). METHODS: EA was diagnosed through oral food challenge (OFC) or recent history of anaphylaxis following egg contact. Skin prick test (SPT) with YFV was performed in all participants (starting at 1:10 dilution for patients with anaphylaxis history and full strength for all others). If negative SPT, an intradermal test (IDT) was performed at 1:100 dilution. If negative IDT, a full dose of YFV was administered, followed by an observation period of 2 hours. If positive skin test, the YFV was administered using a graded-dose protocol. RESULTS: Twenty-five patients with IgE-mediated EA were studied (15M:10F, median age of 2.3y). Ten patients reported prior anaphylaxis, three of whom recently. The other 22 had a positive OFC. SPT with YFV was negative in all patients. IDTwas negative in 20 patients, who received a full dose of YFV in usual manner, uneventfully. Five patients had a positive IDT and received the YFV in graded doses. Two patients presented a mild reaction controlled with antihistamines only and three patients received the vaccine without reactions. CONCLUSIONS: In an appropriate setting, skin testing with vaccine and the use of a graded-dose protocol for high-risk patients allowed a safe administration of the YFV to egg-allergic patients, even with prior risk of anaphylaxis.
